Back to Search
SAIF-ELDIN FARAG, DO
DO
Internal Medicine Physician
NPI: 1689314585IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
81770-21(WI)
CMS Specialties
PrimaryHOSPITALIST
Education
OTHER
Class of 2022
Research & Publications (20)
New isoflavone glycosides from Iris spuria L. (Calizona) cultivated in Egypt.
PMID 18791667·J Nat Med·2009
8-other
Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma.
PMID 19261329·Leuk Res·2009
3-trial
Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma.
PMID 18082257·Leuk Res·2008
3-trial
Antimyeloma effects of a sesquiterpene lactone parthenolide.
PMID 18347184·Clin Cancer Res·2008
8-other
Fructose-amino acid conjugate and other constituents from Cyperus rotundus L.
PMID 19023813·Nat Prod Res·2008
8-other
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation.
PMID 18541197·Biol Blood Marrow Transplant·2008
3-trial
Musculoskeletal affections among kidney recipients: prevalence and risk predictors.
PMID 18443795·Rheumatol Int·2008
8-other
Multiple myeloma. Clinical practice guidelines in oncology.
PMID 17335683·J Natl Compr Canc Netw·2007
6-review
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.
PMID 17317850·Blood·2007
8-other
OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
PMID 17699852·Clin Cancer Res·2007
8-other
Negative selection of hematopoietic progenitor cells by continuous magnetophoresis.
PMID 17379076·Exp Hematol·2007
8-other
A new steroid glycoside and furochromones from Cyperus rotundus L.
PMID 17479423·Nat Prod Res·2007
7-preclinical
A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation.
PMID 17697744·Exp Hematol·2007
8-other
High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma.
PMID 17070906·Leuk Res·2007
8-other
Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis.
PMID 17009321·Biotechnol Bioeng·2007
8-other
Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples.
PMID 16518837·Biotechnol Bioeng·2006
4-observational
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
PMID 16522815·Blood·2006
8-other
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
PMID 16864058·Biol Blood Marrow Transplant·2006
8-other
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
PMID 17162217·Biol Blood Marrow Transplant·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 202 S PARK ST, MERITER HOSPITAL
MADISON, WI 53715 - Phone
- (608) 417-5695
Quick Facts
- NPI
- 1689314585
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile